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Abstract
Background: Patients with symptomatic intracranial atherosclerosis (ICAS) of $70% luminal stenosis are at high risk of
stroke recurrence. We aimed to evaluate the relationships between hemodynamics of ICAS revealed by computational fluid
dynamics (CFD) models and risk of stroke recurrence in this patient subset.
Methods: Patients with a symptomatic ICAS lesion of 70–99% luminal stenosis were screened and enrolled in this study.
CFD models were reconstructed based on baseline computed tomographic angiography (CTA) source images, to reveal
hemodynamics of the qualifying symptomatic ICAS lesions. Change of pressures across a lesion was represented by the ratio
of post- and pre-stenotic pressures. Change of shear strain rates (SSR) across a lesion was represented by the ratio of SSRs at
the stenotic throat and proximal normal vessel segment, similar for the change of flow velocities. Patients were followed up
for 1 year.
Results: Overall, 32 patients (median age 65; 59.4% males) were recruited. The median pressure, SSR and velocity ratios for
the ICAS lesions were 0.40 (22.46–0.79), 4.5 (2.2–20.6), and 7.4 (5.2–12.5), respectively. SSR ratio (hazard ratio [HR] 1.027;
95% confidence interval [CI], 1.004–1.051; P = 0.023) and velocity ratio (HR 1.029; 95% CI, 1.002–1.056; P = 0.035) were
significantly related to recurrent territorial ischemic stroke within 1 year by univariate Cox regression, respectively with the
c-statistics of 0.776 (95% CI, 0.594–0.903; P = 0.014) and 0.776 (95% CI, 0.594–0.903; P = 0.002) in receiver operating
characteristic analysis.
Conclusions: Hemodynamics of ICAS on CFD models reconstructed from routinely obtained CTA images may predict
subsequent stroke recurrence in patients with a symptomatic ICAS lesion of 70–99% luminal stenosis.
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Introduction
Patients with ischemic stroke or transient ischemic attack
(TIA) due to intracranial atherosclerosis (ICAS) face a high risk
of stroke recurrence, especially in lesions with 70–99% luminal
stenosis, which are commonly considered as anatomically severe
lesions [1–3]. An ICAS lesion responsible for an ischemic stroke
or TIA is commonly termed as symptomatic ICAS. According
to the Warfarin versus Aspirin for Symptomatic Intracranial
Disease (WASID) trial and the Stenting and Aggressive Medical
Management for Preventing Recurrent Stroke in Intracranial
Stenosis (SAMMPRIS) trial, those with symptomatic ICAS of
70–99% luminal stenosis could face a risk of recurrent stroke up
to 20% at 1 year, despite of medical or interventional therapies
[2–4]. Thus, the severity of luminal stenosis has been regarded
as an indicator to guide clinical decisions in scenarios of
symptomatic ICAS or patients’ selection for relevant clinical
trials [5]. However, the percentage of luminal stenosis only
represents one aspect of ICAS, which as a complex disease has
many aspects that are probably related to prognosis of
symptomatic ICAS, for instance, plaque characteristics, perfu-
sion status downstream, and presence of collaterals [6–8].
Despite the increasing emphasis on hemodynamic significance of
the lesion in diagnosing coronary artery disease (CAD) by
cardiologists in the past decade [9,10], hemodynamic charac-
teristics of ICAS has been paid little attention.
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Previously the feasibility of reconstructing computational fluid
dynamics (CFD) models of ICAS lesions based on routinely
obtained computed tomographic angiography (CTA) source
images has been demonstrated. And an index termed pressure
ratio has been developed to represent the change of pressures
across an ICAS lesion, which was the ratio of pressures distal and
proximal to the lesion [11]. Physiologically, blood pressure
declines with blood flowing distally, though the pressure gradient
is minimal in normal arteries [12]. Thus, the distal to proximal
pressure ratio in a symptomatic ICAS lesion is theoretically
constantly less than 1, with a lower pressure ratio indicating a
hemodynamically more significant lesion, similar with the
noninvasively simulated fractional flow reserve (FFR) for CAD
[10]. Moreover, according to a previous study investigating flow
patterns in intracranial atherosclerotic disease by using the CFD
technique, highest shear strain rates (SSR) and blood flow
velocities could be detected at the throat of stenosis [13]. It also
has been demonstrated that increased shear rates in the case of
arterial stenosis have a definite impact on platelet activation,
adhesion and aggregation, and may play a role in destabilization
of atherosclerotic plaques [14–18]. Therefore, in this study, we
aimed to evaluate hemodynamic characteristics of ICAS as
depicted by CFD models, including changes of pressure, SSR
and flow velocity across the lesion, and to investigate the
relationships between these hemodynamic parameters and risk of
stroke recurrence, in patients receiving medical treatment for a




This was a retrospective cohort study approved by the Joint
Chinese University of Hong Kong-New Territories East Cluster
Clinical Research Ethics Committee, Hong Kong SAR, China,
which was conducted according to the principles expressed in the
Declaration of Helsinki. All patients were screened and selected
from a prospectively collected dataset at Prince of Wales Hospital,
Hong Kong SAR, China, for which they or their legal
representatives had provided written informed consent.
Subjects
Patients with a symptomatic ICAS lesion of 70–99% luminal
stenosis were screened from a prospectively collected dataset at
Prince of Wales Hospital (December 2006 to February 2012),
Hong Kong SAR, China, and were enrolled according to the
following criteria: 1) adult ischemic stroke or TIA patients
admitted within one week of ictus; 2) patient undergoing clinically
indicated CTA and digital subtraction angiography (DSA)
examinations of intracranial arteries; 3) the stroke or TIA was
due to ICAS of 70–99% luminal stenosis diagnosed by DSA,
located at M1 segment of middle cerebral artery (MCA-M1),
intracranial portion of internal carotid artery (ICA), intracranial
portion of vertebral artery, or basilar artery; 4) receiving routine
medical treatment, for instance, antiplatelet therapy and risk factor
control; 5) with 1 year regular follow-up. Those underwent
interventional angioplasty of the target ICAS during hospitaliza-
tion were excluded from this study.
Demographics, histories of common diseases (previously diag-
nosed or taking corresponding medications at baseline), charac-
teristics of the index event (ischemic stroke or TIA), results of
laboratory tests at baseline, and percentage of luminal stenosis on
DSA, were retrospectively collected from clinical records and
radiology reports. The percentage of cross-sectional stenosis by
DSA was calculated as the percentage of reduction in the vessel
cross-sectional area based on the percentage of luminal stenosis,
assuming that the vessel lumen and the ICAS lesion were circular
and symmetric. For instance, ICAS lesions of 70%, 80%, and 90%
luminal stenosis by DSA were respectively calculated to be of 91%,
96%, and 99% cross-sectional stenosis. CTA source images were
retrieved and reconstructed to CFD models for evaluation of
hemodynamic characteristics of the ICAS lesions as detailed
below. Follow-up data at 1 year were retrieved from the
prospectively collected dataset, and retrospectively confirmed
against clinical records. Primary endpoint was defined as recurrent
ischemic stroke in the territory (SIT) of the qualifying artery within
1 year after the index stroke, confirmed by new ischemic lesions
on follow-up brain CT or magnetic resonance imaging. Secondary
endpoints included any recurrent ischemic stroke or TIA, and all-
cause death.
CFD Modeling
Routinely obtained CTA source images were retrieved from the
Picture Archiving and Communication System at the hospital,
which were then anonymized and stored for CFD simulation of
blood flow. The arterial segment containing a target ICAS lesion
was visually identified and selected on CTA images, which was
then segmented using a gradient-driven level set method to extract
the vascular volume [19]. Centerlines were computed from
selected inlet and outlet points placed at the extreme points of
the vessel segment. Vessel diameters along the centerlines were
derived using the Voronoi method, which allowed construction of
three-dimensional (3D) vessel geometry. A mesh of the 3D surface,
composed of approximately 500,000 tetrahedral cells, was then
created using ANSYS ICEM-CFD (ANSYS, Inc.). Blood flow
simulation was performed on this mesh using ANSYS CFX
software. Generation of mesh and simulation of blood flow were
run on a Cray CX1 cluster (Cray Inc.).
The following settings and assumptions were applied in
construction of CFD models and simulation of blood flow. 1)
Rigid, non-compliant walls with no-slip boundary conditions were
assumed, as with the assumptions applied in the limited number of
preceding studies on CFD of intracranial arterial stenosis [13,20].
2) The inlet pressure was set to be 120 mmHg, based on previous
findings that mean blood pressure proximal to occlusive lesions at
terminal ICA or proximal MCA, measured during intra-arterial
thrombolysis, were only slightly lower than systemic blood
pressure, in lesions with various degrees of luminal stenosis [21].
3) The mean flow velocity at the outlet was prescribed as
60 cm?s21, which is a typical mean flow velocity of cerebral
arteries. 4) Blood was an incompressible Newtonian fluid with a
constant viscosity of 0.004 kg?m21?s21 and was modeled based on
the Navier-Stokes equations [22]. 5) Blood had a density of
1,060 kg?m23.
Evaluation of Hemodynamics of ICAS on CFD Models
Simulated CFD models were post-processed in ANSYS CFX-
post (ANSYS, Inc.) for extraction and evaluation of hemodynamic
parameters. For each ICAS lesion, changes of pressure, SSR, and
flow velocity across the lesion were evaluated on the CFD model,
by calculating the pressure, SSR, and velocity ratios with the
following methods. The pressure ratio was calculated as the ratio
of post- and pre-stenotic pressures (unit: mmHg), which were
respectively measured at the 1st anatomically normal diameters
distal and proximal to an ICAS lesion, using spherical volumes-of-
interest with the same size within the vessel domain (Figure 1A).
SSR ratio of an ICAS lesion was calculated as the ratio of mean
SSR (unit: s21) at the stenotic throat and mean SSR at pre-stenotic
CFD Modeling of Symptomatic ICAS
PLOS ONE | www.plosone.org 2 May 2014 | Volume 9 | Issue 5 | e97531
vessel segment, which were respectively measured at the throat of
stenosis and at the 1st anatomically normal diameter proximal to
the lesion, by using cut-planes perpendicular to the direction of
blood flow (Figure 1B). Similar with measurement of SSRs and
calculation of the SSR ratio, flow velocities (unit: m?s21) were also
measured at these two cut-planes and the velocity ratio was
accordingly calculated (Figure 1C).
Statistical Analyses
Demographics, medical histories, anatomic and hemodynamic
characteristics of the ICAS lesions, and primary and secondary
endpoint events, were described using means 6 standard
deviation, medians (interquartile range) or numbers (%). All
variables were compared between patients with or without SIT
within 1 year, by using Wilcoxon rank-sum tests or Fisher’s
exact tests, respectively for continuous and categorical variables.
All hemodynamic indices were then analyzed in univariate Cox
regression for the endpoint of SIT, as well as other variables
with P,0.10 in Wilcoxon rank-sum tests or Fisher’s exact tests,
to calculate the hazard ratios (HR) and the 95% confidence
intervals (CI) of the predictors for SIT within 1 year. For
hemodynamic indices that were statistically significant in
univariate Cox regression, Kaplan-Meier curves were performed
to detect the cumulative probabilities of SIT based on different
levels of the parameters, and receiver operating characteristic
(ROC) curves and the c-statistics were performed to evaluate
Figure 1. Evaluation of computational fluid dynamics model of an atherosclerotic lesion of left middle cerebral artery. A: Post- and
pre-stenotic pressures were measured using spherical volumes-of-interest (VOI, double arrows) at the first anatomically normal diameters distal (VOI
1) and proximal (VOI 2) to the lesion, respectively. The pressure ratio was calculated by dividing the mean pressure at VOI 1 by the mean pressure at
VOI 2. B: Shear strain rates (SSR) were respectively measured at the stenotic throat (cut-plane 1) and at the first anatomically normal diameter (cut-
plane 2) proximal to the lesion, by using cut-planes perpendicular to the direction of blood flow (arrow). The SSR ratio was calculated by dividing the
SSR averaged over cut-plane 1 by the SSR averaged over cut-plane 2. C: Velocities were similarly measured (arrow) as with the SSRs, and the velocity
ratio was similarly calculated as with the SSR ratio.
doi:10.1371/journal.pone.0097531.g001
CFD Modeling of Symptomatic ICAS
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the predictive values of these parameters for subsequent SIT.
All statistical analyses were performed using PASW Statistics
(version 18.0; IBM SPSS Statistics, Chicago, U.S.A) and
MedCalc (version 11.4; MedCalc Software, Ostend, Belgium).
Two-sided p-values of ,0.05 were considered statistically
significant.
Results
Overall, 32 patients (median age of 65; 59.4% males) with
symptomatic ICAS of 70–99% luminal stenosis were recruited into
this study, among whom 27 (84.4%) cases were ischemic stroke at
baseline with a median National Institutes of Health Stroke Scale
(NIHSS) of 2 (1–3), others being TIA. Twenty-seven (84.4%), 24
(75.0%), 13 (40.6%), 5 (15.6%) and 0 patients had histories of
dyslipidemia, hypertension, diabetes, prior ischemic stroke/ TIA,
and ischemic heart disease, respectively. Detailed information on
demographics, medical histories and results of laboratory tests of
these patients are shown in Table 1.
Anatomic and Hemodynamic Characteristics of the ICAS
lesions
For the qualifying ICAS lesions evaluated in this study, 23
(71.9%), 7 (21.9%), and 2 (6.2%) lesions respectively located at
MCA-M1, intracranial portion of ICA, and vertebrobasilar
arteries. Anatomic and hemodynamic indices of these lesions are
shown in Table 1. The median percentages of luminal stenosis and
cross-sectional stenosis of these ICAS lesions were 76% (70–87%)
and 94% (91–98%) by DSA, respectively. For the evaluation of
reconstructed CFD models, the median values of pressure ratio
was 0.40 (22.46–0.79). The median SSRs measured at the throat
of stenosis and at the 1st anatomically normal diameter proximal to
the lesions were 3,793 (1,888–12,570) and 948 (520–1,382) s21,
respectively. The median flow velocities measured at the two same
cut-planes were 4.7 (2.6–9.9) and 0.7 (0.4–0.8) m?s21, respectively.
Median SSR ratio and velocity ratio for the 32 ICAS lesions were
4.5 (2.2–20.6) and 7.4 (5.2–12.5), respectively.
Comparison of Characteristics between Patients with and
without SIT
The primary endpoint of SIT at 1 year was identified in 6
(18.8%) patients, and secondary endpoints of any recurrent
ischemic stroke or TIA, and all-cause death, occurred in 10
(31.3%) and 1 (3.1%) patients, respectively. Results for comparison
of demographics and medical histories of the patients, and
anatomic and hemodynamic indices of the symptomatic ICAS
lesions, are shown in Table 1. For all these variables, only the
baseline glycosylated hemoglobin level (P = 0.030), and the SSR
ratio (P = 0.038) and velocity ratio (P = 0.038) of ICAS on the CFD
models, were significantly different between patients with and
without the primary endpoint of SIT. However, the percentages of
luminal stenosis (80% versus 76%; P= 0.697), or cross-sectional
stenosis (95% versus 94%, P= 0.697) by DSA, were not
Table 1. Baseline characteristics of all patients, and patients with and without recurrent ischemic stroke in the territory of the
qualifying artery.
Characteristics a Overall (N=32) Recurrent ischemic stroke in the territory P values b
Yes (n =6) No (n=26)
Baseline characteristics
Age, y 65 (57–72) 65 (54–70) 65 (58–74) 0.612
Male 19 (59.4) 3 (50.0) 16 (61.5) 0.666
Current smoker 15 (46.9) 3 (50.0) 12 (46.2) 1.000
History of dyslipidemia 27 (84.4) 6 (100) 21 (80.8) 0.555
History of hypertension 24 (75.0) 5 (83.3) 19 (73.1) 1.000
History of diabetes mellitus 13 (40.6) 4 (66.7) 9 (34.6) 0.194
History of ischemic stroke / TIA 5 (15.6) 1 (16.7) 4 (15.4) 1.000
Laboratory tests
Fasting blood glucose, mmol/L 6.862.4 7.6 (5.3–12.9) 5.7 (5.2–7.1) 0.109
Glycosylated hemoglobin, % 6.661.6 7.8 (6.1–10.9) 6.1 (5.6–6.5) 0.030
Triglycerides, mmol/L 1.660.8 1.5 (1.1–3.1) 1.3 (1.2–1.7) 0.546
High-density lipoprotein, mmol/L 1.260.4 0.9 (0.8–1.4) 1.1 (1.0–1.4) 0.190
Low-density lipoprotein, mmol/L 3.461.3 3.5 (1.4–4.9) 3.4 (2.6–4.0) 0.981
Characteristics of ICAS
Percentage of luminal stenosis by DSA, % 76 (70–87) 80 (71–87) 76 (70–84) 0.697
Percentage of cross-sectional stenosis by DSA, % 94 (91–98) 95 (91–98) 94 (91–97) 0.697
Hemodynamic characteristics on CFD models
Pressure ratio 0.40 (22.46–0.79) 20.80 (246.48–0.78) 0.47 (22.28–0.80) 0.412
SSR ratio 4.5 (2.2–20.6) 22.6 (8.4–87.9) 3.5 (1.9–9.1) 0.038
Velocity ratio 7.4 (5.2–12.5) 12.1 (9.1–77.1) 6.5 (4.7–12.0) 0.038
TIA, transient ischemic attack; ICAS, intracranial atherosclerosis; DSA, digital subtraction angiography; CFD, computational fluid dynamics; SSR, shear strain rate.
aValues are means 6 standard deviation, medians (interquartile range) or numbers (%).
bP values for Wilcoxon rank-sum tests or Fisher’s exact tests, respectively for continuous and categorical variables.
doi:10.1371/journal.pone.0097531.t001
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significantly different between those with or without SIT.
Demographics, medical histories, and results of other laboratory
tests, did not significantly differ between the two groups, either.
Predictors of SIT
Results of univariate Cox regression for predictors of SIT in
these patients are shown in Table 2. Elevated baseline
glycosylated hemoglobin level (HR 1.475; 95% CI, 1.116–
1.950; P= 0.006), and higher SSR ratio (HR 1.027; 95% CI,
1.004–1.051; P= 0.023) and velocity ratio (HR 1.029; 95% CI,
1.002–1.056; P= 0.035) of ICAS on the CFD models, were
found to be significantly correlated to recurrent ischemic stroke
in the territory of the qualifying artery at 1 year. Lower
pressure ratio of ICAS on CFD models tended to be related to
higher risk of subsequent SIT, but not statistically significant
(HR 0.984; 95% CI, 0.966–1.002; P = 0.074).
Kaplan-Meier curves for the cumulative probabilities of SIT in
patients with ICAS lesions with SSR ratios of $ or , median are
shown in Figure 2. In patients with symptomatic ICAS lesions of
70–99% luminal stenosis, those with a SSR ratio $ median may
face a higher risk of recurrent ischemic stroke in the territory of the
stenotic artery (HR 5.483; 95% CI, 1.105–27.211; log-rank
P=0.079), as compared with those with a SSR ratio , median.
The same trend was found for patients with ICAS lesions with a
velocity ratio of $ or , median (HR 5.483; 95% CI, 1.105–
27.211; log-rank P=0.079), as shown in Figure 3. ROC analyses
revealed substantial predictive values of SSR ratio and velocity
ratio for subsequent SIT within 1 year after an ischemic stroke or
TIA due to symptomatic ICAS of 70–99% luminal stenosis, with
the c-statistics of 0.776 (95% CI, 0.594–0.903; P= 0.014) and
0.776 (95% CI, 0.594–0.903; P= 0.002), respectively (Figure 4).
Discussion
In this study, we applied the CFD technique in simulating
blood flow through intracranial atherosclerotic lesions based on
CTA images. Of the 32 patients with symptomatic ICAS of 70–
99% luminal stenosis, 18.8% had a recurrent ischemic stroke in
the territory of the target artery within 1 year after the index
event, which was comparable to the WASID and SAMPPRIS
trials [2–4,23]. We found that the changes of shear strain rates
and blood flow velocities across the lesions, as evaluated on the
CFD models, were significantly related to SIT at 1 year, with
substantial predictive values by ROC analyses.
The target patients of this study were those with a symptomatic
ICAS lesion of 70–99% luminal stenosis, though some may argue
that further risk stratification of such lesions, which have already
been defined as of ‘‘high risk’’ in relevant clinical trials, may not be
of clinical significance. However, many of these patients are
probably not truly at high risk, based on the WASID and
SAMPPRIS trials [1,3,4], and increasing evidences are suggesting
that the severity of luminal stenosis is probably not the only or the
most important indicator for the risk of stroke recurrence in these
patients. Therefore, using a simple parameter of percent stenosis to
stratify such lesions may be misleading [24]. For instance, at least
in this preliminary study, neither the percentages of luminal
stenosis of the ICAS lesions by DSA, nor the hence estimated
severities of cross-sectional stenosis, were different between those
with or without SITs. Thus, a simple measure or estimation of the
severity of arterial stenosis, either luminal or cross-sectional, may
not be an optimal indicator for patient selection in clinical trials
investigating the effects of different treatment strategies for patients
with symptomatic ICAS lesions, which may be one of the reasons
to explain the negative findings in previous relevant trials. For
instance, the SAMMPRIS trial did not prove the benefit of
stenting over aggressive medical treatment for patients with
symptomatic ICAS of 70–99% luminal stenosis [4]. Moreover,
the Trial of Cilostazol in Symptomatic Intracranial Arterial
Stenosis II (TOSS-2) failed to show significant difference between
2 dual antiplatelet therapies in preventing progression of ICAS
and new ischemic lesions, in patients with symptomatic ICAS of
mild to severe luminal stenosis [25]. Thus, in this study we tried to
investigate the clinical relevance of hemodynamic characteristics
of symptomatic ICAS of 70–99% luminal stenosis, which
theoretically incorporated effects of all morphological features of
such lesions, to bring new insights into patient selection for
relevant clinical trials and risk stratification of affected patients.
The inclusion criterion for the percentage of stenosis in this
study was based on DSA images, which is currently the gold
standard for evaluating arterial luminal stenosis. Although biplane
DSA images could also be reconstructed to CFD models [26],
computational models in this study were based on CTA source
images, which by themselves provide three-dimensional informa-
tion. In addition, CFD simulation of hemodynamics of ICAS
based on CTA is probably more generalizable for clinical or
research purposes, with CTA being a non-invasive and more
commonly used imaging modality, in contrast to DSA. In this
study, hemodynamic characteristics of ICAS from CFD models
based on CTA images were more associated with recurrent SIT at
1 year, as compared with the percentage of arterial stenosis by
DSA. In future studies of this kind, we therefore could eliminate
the need for grading the degree of stenosis by DSA, but only rely
on CTA images to build the CFD models of symptomatic ICAS
lesions, so that the noninvasively obtained CTA images, combined
with post-processed CFD models, could provide not only anatomic
but also hemodynamic information of ICAS lesions. Pressure ratio
of an ICAS lesion in this study, was derived from the concept of
FFR in coronary artery disease [12]. Since blood pressure drops
through an arterial stenosis, the pressure ratio of ICAS in this
study, or FFR of CAD, has a theoretical normal value of 1, with
Table 2. Results of univariate Cox regression for predictors of recurrent ischemic stroke in the territory of the qualifying artery.
Characteristics HR (95% CI) P values
Glycosylated hemoglobin, % 1.475 (1.116–1.950) 0.006
Hemodynamic characteristics on CFD models
Pressure ratio 0.984 (0.966–1.002) 0.074
SSR ratio 1.027 (1.004–1.051) 0.023
Velocity ratio 1.029 (1.002–1.056) 0.035
HR, hazard ratio; CI, confidence interval; SSR, shear strain rate.
doi:10.1371/journal.pone.0097531.t002
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lower values indicating hemodynamically more significant lesions
[12]. A trend, though not statistically significant, was found in this
study that lower pressure ratio of ICAS might be related to a
higher risk of subsequent SIT. Future studies with larger sample
sizes, or enrolling patients with wider profiles of percent stenosis,
may further verify such relationships. Minus values of distal
pressure and hence minus pressure ratios in CFD models of some
cases in this study, as shown in Table 1, were probably attributed
Figure 2. Kaplan-Meier curves for the cumulative probabilities of recurrent ischemic stroke in the territory (SIT) of the stenotic
artery within 1 year after ictus, according to the shear strain rate (SSR) ratio ($ or , median) as evaluated on the computational
fluid dynamics models. Intracranial atherosclerotic lesions with a SSR ratio of $ median may relate to a higher risk of SIT, compared with lesions
with a SSR ratio of , median (HR 5.483; 95% CI, 1.105–27.211; log-rank P = 0.079).
doi:10.1371/journal.pone.0097531.g002
Figure 3. Kaplan-Meier curves for the cumulative probabilities of recurrent ischemic stroke in the territory (SIT) of the stenotic
artery within 1 year after ictus, according to the velocity ratio ($ or , median) as evaluated on the computational fluid dynamics
models. Intracranial atherosclerotic lesions with a velocity ratio of $median may relate to a higher risk of SIT, compared with lesions with a velocity
ratio of , median (HR 5.483; 95% CI, 1.105–27.211; log-rank P= 0.079).
doi:10.1371/journal.pone.0097531.g003
CFD Modeling of Symptomatic ICAS
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to the prescribed outflow velocity or extremely low downstream
flow, which could occur in simulated blood flow models but not in
arteries in vivo. This was a limitation of this study that is further
discussed below.
Shear strain rate of blood flow within the vessel lumen
represents the spatial gradient of flow velocity or changes of flow
velocity between infinitesimally thin layers of blood flow [13].
Increased flow velocity at the stenotic throat usually lead to
increased SSR. The absolute values of SSR varied to a great
extend among lesions with various flow patterns, so we used the
ratio of SSRs measured at the stenosis throat and the proximal
normal vessel segment, to represent changes of SSRs through a
lesion, similarly for the use of velocity ratio. According to the
results, higher velocity ratio or SSR ratio of ICAS correlated to
increased risk of stroke recurrence, which may be explained by the
effects of increased SSR on platelet functions [15]. Previous studies
have found definite impact of increased shear rates in the case of
arterial stenosis on platelet activation, adhesion and aggregation,
and hence thrombus formation, through different pathways under
different ranges of shear rates [14–16]. Moreover, endothelial
shear stress (ESS) at the neck of a stenotic plaque, which is
proportional to the product of local SSR and blood viscosity, may
play a role in destabilization of atherosclerotic plaques [17,18].
Further in vivo and in vitro studies are needed to validate potential
mechanisms for findings in this study on the association between
high SSR of ICAS and risk of stroke recurrence.
Our study has limitations. Firstly, the small sample size, and
hence the small number of recurrent events in this study, did not
allow multivariate analyses for adjustment of potential confound-
ing factors, which therefore limited generalization of the study
results. Some of the correlations found in this study did not reach
statistical significance, which probably was also due to the small
sample size. But this could be addressed in future studies with
larger sample sizes. In addition, this study only enrolled patients
with symptomatic ICAS of 70–99% luminal stenosis. Future
studies performed in lesions with various degrees of stenosis are
needed to facilitate better understanding of this disease, consid-
ering the fact that nearly half of the recurrent strokes in patients
with symptomatic ICAS occurred in those with lesions of 50–69%
luminal stenosis in the WASID trial [27]. Secondly, some minus
distal pressure values as detected were probably due to the effects
of the prescribed flow velocity at the outlet of the models in cases
with minimal distal flow, which could be addressed in future
studies by setting opening boundary conditions at the outlet, or by
setting personalized outflow velocities based on flow velocities
measured by transcranial Doppler or other methods. Moreover, a
constant pressure rather than more patient-specific, physiological
pulsatile pressures used as inlet boundary conditions in this study
may reduce the accuracy and realisticity of the CFD models. But
such effects of this generic constant inlet pressure may be
mitigated, since we were using relative pressure ratios but not
absolute pressure values to represent the changes of pressures
across the symptomatic ICAS lesions. Thirdly, for intracranial
arteries, it may not be possible to validate the pressures derived
from CFD models against in vivo measurement, by floating a
pressure sensor during the performance of catheter angiography,
as is currently done for the assessment of coronary arterial
pressures. It will arouse ethical issues, to invasively measure
intracranial arterial pressures only for a diagnostic purpose while
risking periprocedural complications of DSA. However, the
hemodynamic impact of ICAS lesions as revealed by CFD models
may be indirectly validated by comparing with findings from
imaging methods capable of selectively quantifying regional
cerebral blood flow, such as vessel-selective arterial spin-labeling
magnetic resonance perfusion [28].
Conclusions
Hemodynamic characteristics of ICAS, as evaluated on CFD
models reconstructed from routinely obtained CTA images, may
predict subsequent risk of stroke recurrence in patients with
symptomatic ICAS of 70–99% luminal stenosis. Future prospec-
tive studies with larger sample sizes are warranted to further
validate findings of this study, which may shed new light on risk
stratification of this patient subset.
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Figure 4. Receiver operating characteristic curves for shear strain rate ratio (left) and velocity ratio (right) to predict recurrent
ischemic stroke in the territory of the qualifying artery. SIT indicates recurrent ischemic stroke in the territory of the qualifying artery; AUC,
area under curve.
doi:10.1371/journal.pone.0097531.g004
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